# Monte Rosa Therapeutics

> biotechnology company

**Wikidata**: [Q115011580](https://www.wikidata.org/wiki/Q115011580)  
**Source**: https://4ort.xyz/entity/monte-rosa-therapeutics

## Summary
Monte Rosa Therapeutics is a biotechnology company operating as a public entity, offering securities to the general public through its Nasdaq listing under the ticker symbol GLUE since June 2021. It specializes in the biotechnology industry and maintains an online presence via its English-language website.

## Key Facts
- Industry: Biotechnology
- Instance of: Company, Public company
- Stock exchange: Nasdaq (ticker: GLUE, listing start: June 2021)
- Website: https://www.monterosatx.com/ (language: English)
- Wikidata description: Biotechnology company

## FAQs
**What industry does Monte Rosa Therapeutics operate in?**  
Monte Rosa Therapeutics is a biotechnology company focused on developing and advancing biotechnological innovations and therapies.

**Is Monte Rosa Therapeutics publicly traded?**  
Yes, it is a public company listed on the Nasdaq stock exchange, allowing its securities to be traded by the general public.

**Where can Monte Rosa Therapeutics stock be purchased?**  
Its shares are traded on the Nasdaq exchange under the ticker symbol GLUE, with trading commencing in June 2021.

**What is Monte Rosa Therapeutics' official website?**  
The company operates an English-language website at https://www.monterosatx.com/.

## Why It Matters
As a publicly traded biotechnology company, Monte Rosa Therapeutics plays a role in advancing biotechnological research and development through access to public capital markets. Its Nasdaq listing enables broader investor participation and funding for biotechnology initiatives, contributing to innovation in the sector while adhering to regulatory transparency standards required of public entities.

## Notable For
- Being a public biotechnology company with securities available to general investors
- Nasdaq listing under the ticker symbol GLUE since June 2021
- Operating exclusively within the biotechnology industry
- Maintaining an English-language corporate website

## Body
### Overview
Monte Rosa Therapeutics is classified as both a company and a public company, defining its core operational and structural characteristics. Its primary industry focus is biotechnology, aligning with its mission to develop and commercialize biotechnological solutions. The entity is recognized as a public company, meaning it offers securities to the general public through regulated stock exchanges.

### Corporate Structure
As a public company, Monte Rosa Therapeutics operates under the legal and regulatory framework applicable to publicly traded entities. This structure allows it to raise capital by issuing shares to a broad base of investors, distinguishing it from private companies. Its classification as a "company" and "public company" establishes its foundational organizational identity within the corporate landscape.

### Stock Exchange Listing
Monte Rosa Therapeutics is listed on the Nasdaq stock exchange, a major global marketplace for securities trading. Its trading commenced in June 2021, as indicated by the start time qualifier. The company is identified by the ticker symbol GLUE, which serves as its unique identifier for trading and market data purposes. This listing provides liquidity and visibility to investors while subjecting the company to ongoing regulatory compliance requirements.

### Online Presence
The company maintains an official website at https://www.monterosatx.com/, which is explicitly designated as an English-language resource. This digital platform serves as a primary channel for corporate communications, investor relations, and public engagement. The website's language specification (English) reflects its target audience and operational scope.